Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study With an Extension Phase to Evaluate the Pharmacokinetics of Perampanel (E2007) Oral Suspension When Given as an Adjunctive Therapy in Subjects From 1 Month to Less Than 4 Years of Age With Epilepsy

NCT02914314 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT02914314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02914314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study With an Extension Phase to Evaluate the Pharmacokinetics of Perampanel (E2007) Oral Suspension When Given as an Adjunctive Therapy in Subjects From 1 Month to Less Than 4 Years of Age With Epilepsy
Lead sponsor
Eisai Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 20, 2017
Completion date
April 25, 2023
Enrollment
26 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy